Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Cranberry in Reducing Dysbiosis in Patients With Crohn's Disease

NCT07170462 is registered in ClinicalTrials.gov with Ana Maldonado-Contreras as lead sponsor.

NCT NCT07170462
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07170462 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Cranberry in Reducing Dysbiosis in Patients With Crohn's Disease
Lead sponsor
Ana Maldonado-Contreras
Phase
Phase 1
Overall status
Completed
Start date
October 29, 2025
Completion date
August 15, 2026
Enrollment
31 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

crohn disease, crohn disease (cd)